Pulmonary toxicity of wollastonite in vivo and in vitro

Journal of Applied Toxicology

Volumn 24, Issue 2, 2004, Pages 147-154

  Tatrai E ^a   Kovacikova Z ^b   Broozik M ^c   Six, E ^d  

^a National Institute of Occupational Health Budapest   (Hungary)

^b INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

^c NATIONAL INSTITUTE OF RHEUMATOLOGY AND PHYSIOTHERAPY   (Hungary)

^d Foder Jozsef National Centre for Public Health   (Hungary)

Author keywords

Alveolar macrophages; Crocidolite; Cu,ZnSOD; GGT; Glutathione peroxidase; Glutathione reductase; MCP 1; MIP 1 ; Pneumocytes type II; Rats; Wollastonite

Indexed keywords

CALCIUM SILICATE; COPPER ZINC SUPEROXIDE DISMUTASE; CROCIDOLITE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE PEROXIDASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; FIBROSING ALVEOLITIS; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG TOXICITY; MALE; MICROMORPHOLOGY; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT STRAIN;

ANIMALS; ASBESTOS, CROCIDOLITE; BONE SUBSTITUTES; CALCIUM COMPOUNDS; CELLS, CULTURED; CHEMOKINE CCL2; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; IMMUNOHISTOCHEMISTRY; INTUBATION, INTRATRACHEAL; LUNG; MACROPHAGE INFLAMMATORY PROTEIN-1; MACROPHAGES, ALVEOLAR; MALE; PARTICLE SIZE; PULMONARY ALVEOLI; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; SILICATES; SUPEROXIDE DISMUTASE;

EID: 1842716778     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jat.965     Document Type: Article

References (25)

1. Aerts C, Wallaert B, Voisin C. 1992. In vitro effects of hyperoxia on the alveolar type II pneumocytes: inhibition of glutathione synthesis increases hyperoxic cell injury. Exp. Lung Res. 18: 845-861.
2. Asiam M, Arif J, Rahman Q. 1995. Red blood cell damage by wollastonite: in vitro study. J. Appl. Toxicol. 15: 27-31.
3. Barrett EG, Johnston C, Oberörster G, Finkelstein JN. 1999. Silica-induced chemokine expression in alveolar type II cell mediated by TNF-alpha-induced oxidant stress. Am. J. Physiol. 276: 979-988.
4. Bellmann B, Muhle H. 1994. Investigation of the biodurability of wollastonite and xonolite. Environ. Health Perspect. 102: 191-195.
5. Edelson JD, Shannon JM, Mason RJ. 1988. Alkaline phosphatase: a marker of alveolar type II cell differentiation. Am. Rev. Respir. Dis. 138: 1268-1275.
6. Fridovich I. 1986. Superoxide dismutases. Adv. Enzymol. 58: 61-97.
7. Hanke W, Sepulveda MJ, Watson A, Jankovic J. 1983. Respiratory morbidity in wollastonite workers. Br. J. Ind. Med. 41: 474-479.
8. Hoet PHM, Lewis CPL, Demedts M, Nemery B. 1994. Putrescine and paraquat uptake in human lung slices and isolated type II pneumocytes. Biochem. Pharmacol. 48: 517-524.
9. Hook GER. 1978. Extracellular hydrolase of the lung. Biochemistry 1: 520-528.
10. Huuskonen MS, Järvisalo J, Koskinen H, Nickels J, Räsänen and Asp S. 1983a. Preliminary results from a cohort of workers exposed to wollastonite in a Finnish limestone quarry. Scand. J. Work. Environ. Health 9: 169-175.
11. Huuskonen MS, Tossavainen A, Koskinen H, Zitting A. 1983b. Wollastonite exposure and lung fibrosis. Environ. Res. 30: 291-304.
12. IARC. 1997. Silica, some silicates, coal dust and para-aramid fibrils. IARC Monogr. 68: 301.
13. Kelly FJ. 1999. Glutathione: in defence of the lung. Food Chem. Toxicol. 37: 963-966.
14. Klockars M, Hedenborg M, Vanhala E. 1990. Effect of two particle surface-modifying agents, polyvinylpyridine N-oxide and carboxymethylcellulose, on the quartz and asbestos mineral fiber-induced production of reactive oxygen metabolites by human polymorphonuclear leukocytes. Arch. Environ. Health 45: 8-14.
15. Koyama S, Sato E, Nomura H, Kubo K, Miura M, Yamashita T, Nagai S, Izumi T. 1999. Monocyte chemotactic factors released from type II pneumocyte-like cells in response to TNF-alpha and IL-1alpha. Eur. J. Respir. 13: 820-828.
16. McConnell EE, Wagner JC, Skidmore JW, Moore JA. 1984. A comparative study of fibrogenic and carcinogenic effect of UICC Canadian chrysotile B asbestos and glass microfibre (JM 100). In Biological Effects of Man-made Mineral Fibres (Proceedings of WHO/IARC Conference), vol. 2. World Health Organization: Copenhagen, 234-252.
17. Meister A, Anderson ME. 1983. Glutathione. Annu. Rev. Biochem. 52: 711-760.
18. Muhle H, Bellmann, Pott F. 1994. Comparative investigations of the biodurability of mineral fibers in the rat lung. Environ. Health Perspect. 102: 163-168.
19. Pailes WH, Judy DJ, Resnick H, Castranova V. 1984. Relative effects of asbestos and wollastonite on alveolar macrophages. J. Toxicol. Environ. Health 14: 497-510.
20. Paine R, Rolfe MW, Standiford TJ, Burdick MD, et al. 1993. MCP-1 expression by rat type II alveolar epithelial cells in primary culture. J. Immunol. 150: 4561-4570.
21. Rahman I, MacNee W. 2000. Oxidative stress and regulation of glutathione in lung inflammation. Eur. Respir. J. 16: 534-555.
22. Richards RJ, Davies N, Atkins J, Oreffo VIC. 1987. Isolation, biochemical characterization and culture of lung epithelial cell of the rat. Lung 165: 143-158.
23. Szasz G. 1969. A kinetic photometric method for serum gamma glutamyl transpeptidase. Clin. Chem. 15: 124-136.
24. Vallyathan V, Shi X. 1997. The role of oxygen free radicals in occupational and environmental lung diseases. Environ. Health Perspect. 105: 165-177.
25. Warheit DB, Hill LH, Brody AR. 1984. In vitro effects of crocidolite asbestos and wollastonite on pulmonary macrophages and serum complement. Scan. Electron Microsc. ii: 919-926.